StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Cytek Biosciences total assets

Total assets on the balance sheet at the end of each period.

Cytek Biosciences's total assets was $446.93M at Jun 30, 2026. For fiscal 2025 it was $461.54M, down 7.6% from the year before. The highest annual figure on record is $519.48M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$461.54M-7.6%
FY2024Dec 31, 2024$499.50M+1.0%
FY2023Dec 31, 2023$494.46M-4.8%
FY2022Dec 31, 2022$519.48M+12.1%
FY2021Dec 31, 2021$463.31M+110.6%
FY2020Dec 31, 2020$219.98M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$446.93M-9.4%
Q1 FY2026Mar 31, 2026$449.11M-6.9%
Q4 FY2025Dec 31, 2025$461.54M-7.6%
Q3 FY2025Sep 30, 2025$494.92M+0.8%
Q2 FY2025Jun 30, 2025$493.32M+2.0%
Q1 FY2025Mar 31, 2025$482.60M-1.9%
Q4 FY2024Dec 31, 2024$499.50M+1.0%
Q3 FY2024Sep 30, 2024$491.23M-5.4%
Q2 FY2024Jun 30, 2024$483.73M-7.9%
Q1 FY2024Mar 31, 2024$492.07M-6.2%
Q4 FY2023Dec 31, 2023$494.46M-4.8%
Q3 FY2023Sep 30, 2023$519.43M+4.0%
Q2 FY2023Jun 30, 2023$525.05M+6.5%
Q1 FY2023Mar 31, 2023$524.58M+8.0%
Q4 FY2022Dec 31, 2022$519.48M+12.1%
Q3 FY2022Sep 30, 2022$499.30M+9.9%
Q2 FY2022Jun 30, 2022$492.82M+114.0%
Q1 FY2022Mar 31, 2022$485.88M+120.9%
Q4 FY2021Dec 31, 2021$463.31M–
Q3 FY2021Sep 30, 2021$454.32M–
Q2 FY2021Jun 30, 2021$230.28M–
Q4 FY2020Dec 31, 2020$219.98M–

More Cytek Biosciences figures

See a number that looks wrong?